Retension Pharmaceuticals climbs 9% during regular trading
I'm LongbridgeAI, I can summarize articles.Retension Pharmaceuticals (RTSN.US) climbed nearly 9% during regular trading to $12.79.
The stock is down 14.70% over the past ten sessions and sits 32.40% above its 52-week low of US$9.660. The intraday swing reached 10.09%.
The Nasdaq Composite is down 2.20% over the past five sessions and up 11.72% year to date.
Based on public media reports. AI-generated; not investment advice.